{
  "docId": "019de516-a80e-7369-bef2-cb942c391804",
  "docSlug": "7dbeec795af717930d34b2c0014ea723",
  "documentTitle": "Oculis | Results Presentation Deck | 33 slides",
  "authorId": "oculis",
  "authorName": "Oculis",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 26,
  "pageCount": 33,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "comparison_table",
  "function": "compare_peers",
  "density": "dense",
  "nDataPoints": 20,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de516-a80e-7369-bef2-cb942c391804/26",
  "deckHref": "/decks/019de516-a80e-7369-bef2-cb942c391804",
  "deckJsonHref": "/decks/019de516-a80e-7369-bef2-cb942c391804.json",
  "deckAnchorHref": "/decks/019de516-a80e-7369-bef2-cb942c391804#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.05,
        "w": 0.89,
        "x": 0.029,
        "y": 0.923
      },
      "kind": "source-note",
      "text": "ªNo head to head studies.\n1. INVELTYS Prescribing Information. Kala Pharmaceuticals. 2022. 2. DUREZOL Prescribing Information. Novartis. 2020. 3. LOTEMAX SM Prescribing Information. B&L. 2023. 4. Fong R, et al., Clin Ophthalmol. 2019;13:1427-1438",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d39df1da-3d3f-4277-afff-d373fb74521a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.66,
        "w": 0.801,
        "x": 0.099,
        "y": 0.19
      },
      "kind": "table",
      "text": "Source; Active Ingredient; Dosing; ZERO INFLAMMATION (Day 15) % Drug vs vehicle Active Arm; Delta vs vehicle; PAIN FREE (Day 4) % Drug vs vehicle Active Arm; Delta vs vehicle\nOCS-01 Phase 2&3 trials; Dexamethasone 1.5%; 1x/day Phase 3; 57% vs 24%; +33%; Day 4: 75% vs 52%; +23%\nOCS-01 Phase 2&3 trials; Dexamethasone 1.5%; 1x/day Phase 2; 51% vs 20%; +31%; Day 4: 73% vs 45%; +28%\nPhase 3 trial results & Prescribing Information; Loteprednol 1%; 2x/day; 50% vs 27%; +23%; Day 4: 43% vs 25%; +18%\nPhase 3 trial results & Prescribing Information; Difluprednate 0.05%; 4x/day; 41% vs 12%; +29%; Day 8: 58% vs 27%; +21%\nPhase 3 trial results & Prescribing Information; Loteprednol 0.38%; 3x/day; 47% vs 25%; +22%; Day 8: 74% vs 49%; +25%",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "90c05ecd-f78c-4044-9c99-04ca46db7bf4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.029,
        "w": 0.79,
        "x": 0.029,
        "y": 0.055
      },
      "kind": "title",
      "text": "OCS-01 Ph 3 and Ph 2 Results Compared to Current Standard of Care",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb975e68-24cc-4562-8148-997368b1d417",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.72,
        "x": 0.029,
        "y": 0.09
      },
      "kind": "title",
      "text": "Topline efficacy summary with comparators with pain and inflammation labelª",
      "attrs": {},
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e70b7520-183d-4c77-b448-e9d314453dc7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Comparison frame",
      "slug": "comparison-frame",
      "agent": null,
      "layer": "slide",
      "matchId": "267ef396-f0f2-49f4-8d35-7eee14d49388",
      "evidence": "OCS-01 Ph 3 and Ph 2 Results Compared to Current Standard of Care",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}